It's also worth pointing out that CVS Health seems to have plenty of space to increase its dividend. The company's cash ...
Shares of The Bristol-Myers Squibb Company (NYSE: BMY)are attempting to claw their way back into positive territory after the ...
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and ...
CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars: On January 30, 2025, the European Medicines Agency (EMA) Committee ...
Addressing a preliminary injunction in patent litigation related to the Biologics Price Competition and Innovation Act (BPCIA), the US Court ...
What Happened: Grygiel's recent move involves selling 1,589 shares of Amgen. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total ...
Alumis is also developing another tyrosine kinase 2 blocker, A-005, for neuroinflammatory and neurodegenerative conditions ...
Light AI Announces Engagement with Regulatory Partner Emergo by UL for Global Regulatory Submissions
Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness applications, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback